Cyanazine and dichlorvos – a reply

In 1995 the US EPA and the manufacturers DuPont agreed to phase out the herbicide cyanazine over a four year period because of possible human carcinogenicity. EPA also proposed to cancel most uses of the OP dichlorvos because of a risk of cancer from dietary exposure. The Pesticides Trust [now PAN UK] wrote to the UK Advisory Committee on Pesticides for their views on those pesticides in the UK. The following is a summary of the reply.

Cyanazine
Firstly cyanazine will be reviewed as part of the EC review programme ‘in the not too distant future’, and for the reasons that follow, real issues of human or environmental safety do not seem to be involved. Cyanazine is not widely used in the UK. Secondly, EPA display a ‘low level of concern’—the period from beginning to phase out production to the final phase out of use is seven years in total. And thirdly, the ACP has recently reviewed the compounds atrazine and simazine, and takes the view that they are similar compounds and no safety concerns were evident in their cases. Both compounds caused tumours in rats, but ACP concluded that the rat strain used was predisposed to develop the mammary tumours observed. A hormonal mechanism that might have accounted for the tumours in rats was not relevant for humans, and overall the increased levels of tumours were of questionable significance for humans and did not indicate an unacceptable risk.

Dichlorvos
Most uses of dichlorvos are non-agricultural in the UK. The ACP reviewed non-agricultural uses and concluded that dichlorvos was not carcinogenic in the rat and the weight of evidence suggested it did not present a carcinogenic risk to humans or a risk to fertility or reproduction. Agricultural uses will fall to be reviewed by the EC in due course.

[This article first appeared in Pesticides News No. 32, June 1996, page 22]